(Q36411681)

14 August 2017

1 reference

title

Bioinformatics approach to predicting HIV drug resistance (English)

1 reference

14 August 2017

1 reference

3

Joachim Selbig

1 reference

14 August 2017

2

Rolf Kaiser

1 reference

14 August 2017

Frank Cordes

1

1 reference

14 August 2017

publication date

1 March 2006

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

14 August 2017

published in

1 reference

14 August 2017

volume

6

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

207-215

1 reference

Computational methods for the design of effective therapies against drug resistant HIV strains

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

HIV treatment failure: testing for HIV resistance in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Sequence logos: a new way to display consensus sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Predicting HIV drug resistance with neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Enhanced prediction of lopinavir resistance from genotype by use of artificial neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Characterizing the relationship between HIV-1 genotype and phenotype: prediction-based classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Non-parametric methods to predict HIV drug susceptibility phenotype from genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Tenofovir resistance and resensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

PIRSpred: a web server for reliable HIV-1 protein-inhibitor resistance/susceptibility prediction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3'-azido-3'-deoxythymidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Estimating HIV evolutionary pathways and the genetic barrier to drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Coevolutionary analysis of resistance-evading peptidomimetic inhibitors of HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

3D-QSAR: a current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Elucidating the inhibiting mode of AHPBA derivatives against HIV-1 protease and building predictive 3D-QSAR models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

An introduction to kernel-based learning algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.2.207

21 January 2018

Identifiers

DOI

10.1586/14737159.6.2.207

1 reference

14 August 2017

1 reference